Display options
Cite
Ravegnini G, Del Re M, Grolla AA, et al. Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response. Front Pharmacol. 2020;11:598261doi: 10.3389/fphar.2020.598261.
Ravegnini, G., Del Re, M., Grolla, A. A., van Schaik, R. H. N., & Angelini, S. (2020). Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response. Frontiers in pharmacology, 11598261. https://doi.org/10.3389/fphar.2020.598261
Ravegnini, Gloria, et al. "Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response." Frontiers in pharmacology vol. 11 (2020): 598261. doi: https://doi.org/10.3389/fphar.2020.598261
Ravegnini G, Del Re M, Grolla AA, van Schaik RHN, Angelini S. Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response. Front Pharmacol. 2020 Oct 07;11:598261. doi: 10.3389/fphar.2020.598261. eCollection 2020. PMID: 33117183; PMCID: PMC7577116.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2020 Oct 07;11:598261. doi: 10.3389/fphar.2020.598261. eCollection 2020.

Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response.

Frontiers in pharmacology

Gloria Ravegnini, Marzia Del Re, Ambra A Grolla, Ron H N van Schaik, Sabrina Angelini

Affiliations

  1. Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  2. Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  3. Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy.
  4. Department of Clinical Chemistry, Erasmus MC, Rotterdam, Netherlands.

PMID: 33117183 PMCID: PMC7577116 DOI: 10.3389/fphar.2020.598261

[No abstract available.]

Keywords: Circulating molecular marker; ctDNA (circulating tumor DNA); liquid biopsy; personalized medicine; precision oncology

References

  1. Ann Oncol. 2019 Oct 1;30(10):1580-1590 - PubMed
  2. Expert Rev Mol Diagn. 2020 Jun;20(6):575-582 - PubMed

Publication Types